Division of Dermatology, Niigata Cancer Center Hospital, Niigata, Japan.
Division of Dermatology, Niigata University Graduate School of Medicine and Dental Science, Niigata, Japan.
J Dermatol. 2021 Jul;48(7):1098-1100. doi: 10.1111/1346-8138.15876. Epub 2021 Apr 8.
As cancer treatment advances, the need for dermatologists in the treatment process is increasing. Cancer patients often experience cutaneous manifestations of internal diseases and dermatological adverse events from chemotherapy, radiation, surgery, and stem cell transplants. These diminish patients' health-related quality of life and negatively affect cancer treatment adherence. To identify the dermatologist's role, we analyzed 893 cases of in-hospital dermatology consultations at the Niigata Cancer Center Hospital during 2019. The number of dermatology consultations was the second highest among all hospital departments. Malignant tumors accounted for 91.7% of the underlying diseases, including hematological, gastrointestinal, and lung cancer as the top three primary cancers. The most common consultation category was inflammatory skin disorders (29.2%), followed by chemotherapy-related skin disorders (23.5%), cutaneous infections (11.5%), skin tumors (9.5%), and continued treatment of pre-existing skin disorders (8.8%). The average intervention time was the longest for continued treatment of existing skin disorders (229 ± 60.6 days), followed by malignant wound management (126 ± 60.6 days) and chemotherapy-related skin disorders (122 ± 60.6 days). The median overall survival time of the 27 patients in the malignant wound management group was 5 months (95% confidence interval, 1.8-8.2 months) from the initial dermatology consultation. Our results show an increasing demand for dermatologists in cancer management. However, the number of full-time dermatologists is insufficient in some Japanese cancer hospitals. There is a need to consider increasing the number of adequately trained dermatologists in cancer medical settings.
随着癌症治疗的进展，癌症治疗过程中对皮肤科医生的需求也在增加。癌症患者经常会出现内部疾病的皮肤表现，以及化疗、放疗、手术和干细胞移植引起的皮肤科不良反应。这些会降低患者的健康相关生活质量，并对癌症治疗的依从性产生负面影响。为了明确皮肤科医生的角色，我们分析了 2019 年新潟癌症中心医院的 893 例住院皮肤科会诊病例。皮肤科会诊的数量在所有医院科室中排名第二。恶性肿瘤占基础疾病的 91.7%，其中血液系统、胃肠道和肺癌是前三种主要癌症。最常见的咨询类别是炎症性皮肤疾病（29.2%），其次是化疗相关皮肤疾病（23.5%）、皮肤感染（11.5%）、皮肤肿瘤（9.5%）和原有皮肤疾病的持续治疗（8.8%）。平均干预时间最长的是原有皮肤疾病的持续治疗（229±60.6 天），其次是恶性伤口管理（126±60.6 天）和化疗相关皮肤疾病（122±60.6 天）。恶性伤口管理组的 27 名患者的中位总生存期从首次皮肤科会诊开始为 5 个月（95%置信区间，1.8-8.2 个月）。我们的结果表明，癌症管理中对皮肤科医生的需求不断增加。然而，在一些日本癌症医院，全职皮肤科医生的数量不足。有必要考虑在癌症医疗环境中增加经过充分培训的皮肤科医生人数。
